parkinson glutathione oxidative ipsc crispr

parkinson glutathione oxidative ipsc crispr CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease CRISPR/Cas9 assisted stem cell therapy

Name: parkinson glutathione oxidative ipsc crispr CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease CRISPR/Cas9 assisted stem cell therapy
Brand: centoria.fr
SKU: 56026992772
Price: 29.74 USD
Availability: InStock
Rating: 4.2196 (11 reviews)

CRISPR Cas9 assisted stem cell therapy in Parkinson's disease Biomaterials Research Springer Nature Link Using induced pluripotent stem cells for modeling Parkinson's disease Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024 Journal of Molecular Medicine Springer Nature Link Genome editing in Parkinson's disease: Unlocking therapeutic avenues through CRISPR Cas systems ScienceDirect

SKU: 56026992772 · From centoria.fr

4.2

USD29.74 USD64.74

Pay in 4 interest-free payments of $7.43 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 27 - Oct 2

Description

Various bioactive peptides in collagen hydrolysate from salmo salar skin and the combined inhibitory effects on atherosclerosis in vitro and in vivo

Generally, peptides harvested for therapy come from animal or plant protein sources, including eggs, milk, meat, soy, flaxseed hemp seed, and wheat

[44], molecular docking and molecular dynamic simulations revealed that the main bioactive molecules in BFE diminished the inflammatory response driven by LPS+nigericin-medicated NLRP3 activation [44]